Sendurai Mani: I am privileged to present at this distinguished gathering organized by the WIN Consortium in cancer personalized medicine and Burjeel Holdings
Sendurai Mani, Associate Director for Translational Oncology at Brown University Legorreta Cancer Center, shared a post on LinkedIn:
“Precision Oncology is advancing rapidly, aiding in better treatments and improved survival of cancer patients globally. Prof. James Allison, a Nobel laureate, who played a pivotal role in unveiling the potential of immune cells, along with numerous esteemed precision oncologists such as Dr. Wafik S. El-Deiry, MD, PhD, FACP, Director of Brown University’s Legorreta Cancer Center, Razelle Kurzrock, Chair of Precision Oncology at MCW Cancer Center, Dr. Vivek Subbiah, MD, Dr. Hatim Husain, Prof.Humaid Al-Shamsi,MB(IRL),FRCP(Lon),FRCP(Canada),FACP(U.S), Prof. Khaled Musallam, MD, PhD, Prof. Pam Sharma, Dr. Christian Rolfo, MD, PhD, MBA,Dr.h.c., Dr. Vladimir Lazar MD, PhD, Dr. Jacob Scott, Prof. Silvia Formenti, Prof. Don S. Dizon, Dr. Helmy Eltoukhy, Dr. Jason Hipp, MD,PhD, Dr. Justin Guinney, PhD, Dr. Katherine Tossas, and many more, are joining together to explore ways to enhance precision oncology and further contribute to saving lives of cancer patients. I am privileged to present at this distinguished gathering organized by the WIN Consortium in cancer personalized medicine and Burjeel Holdings.”
Source: Sendurai Mani/LinkedIn